JNJ

Johnson & Johnson

• Simply Wall St·3h ago

  Should J&J’s Oncology and MedTech Breakthroughs Prompt a Fresh Look From Johnson & Johnson (JNJ) Investors?

• Seeking Alpha·18h ago

  Insider trades: Johnson & Johnson, TSMC among notable names

• Seeking Alpha·20h ago

  What Moved Markets This Week

• TipRanks·20h ago

  Insiders Shake Up TSMC, Johnson & Johnson, Strategy, Snap, 3M

• Seeking Alpha·1d ago

  Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins

• NASDAQ·1d ago

  Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher

• NASDAQ·1d ago

  Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data

• Seeking Alpha·1d ago

  J&J, Gilead among recipients of EU drug recommendations this week

• The Motley Fool·1d ago

  This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It

• TipRanks·1d ago

  Analysts Are Bullish on Top Healthcare Stocks: Merck & Company (MRK), Johnson & Johnson (JNJ)

• Seeking Alpha·1d ago

  Legend Biotech: Why I'm Ready To Go Long Again

• Seeking Alpha·1d ago

  These mega caps are trading in overbought territory as earnings season heats up

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)

• Dow Jones·1d ago

  Johnson & Johnson Skin Drug Gets Positive Opinion From EU Drug Regulator